Protagonist Therapeutics Inc Share Price Nasdaq
Equities
US74366E1029
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- PTS | - |
Sales 2024 * | 270M 0 22.56B | Sales 2025 * | 120M 0 10.01B | Capitalization | 1.99B 0 166B |
---|---|---|---|---|---|
Net income 2024 * | 77M - 6.43B | Net income 2025 * | 2M - 167M | EV / Sales 2024 * | 5.74 x |
Net cash position 2024 * | 442M 0 36.9B | Net cash position 2025 * | 677M 0 56.59B | EV / Sales 2025 * | 11 x |
P/E ratio 2024 * |
29.5
x | P/E ratio 2025 * |
-34.5
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.96% |
Latest transcript on Protagonist Therapeutics Inc
Managers | Title | Age | Since |
---|---|---|---|
Dinesh Patel
CEO | Chief Executive Officer | 67 | 01/08/01 |
Asif Ali
DFI | Director of Finance/CFO | 50 | 18/22/18 |
Chief Tech/Sci/R&D Officer | - | 01/17/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Lewis Williams
BRD | Director/Board Member | 74 | 08/17/08 |
Harold Selick
CHM | Chairman | 69 | 01/09/01 |
Daniel Swisher
BRD | Director/Board Member | 61 | 26/23/26 |
1st Jan change | Capi. | |
---|---|---|
+49.21% | 56.95B | |
+39.98% | 40.26B | |
-6.86% | 39.32B | |
-4.42% | 28.37B | |
+12.00% | 26.45B | |
-18.27% | 19.41B | |
+29.57% | 12.54B | |
+25.41% | 12.21B | |
-0.35% | 12.15B |